ERN a l'Hospital Germans Trias

ERN at Hospital Germans Trias: Genetic syndromes with tumour risk (ERN GENTURIS).

 

Hospital Germans Trias i Pujol University Hospital is part of the European Reference Network for Genetic Syndromes with Tumour Risk (ERN GENTURIS).

 

 

ERN Genturis is made up of 51 hospitals from 23 countries in the European Union.

 

Patients with rare genetic syndromes with tumour risk have a high hereditary risk of developing multiple tumours, which are often found in several organ systems. If diagnosed with cancer, these people require different treatment and follow-up compared to patients with non-hereditary cancers. The lifetime risk of cancer can be as high as 100%.

 

Germans Trias is part of the European reference network for the following pathologies: 

  • TG1: type 1 neurofibromatosis, type 2 neurofibromatosis and schwannomatosis.

  • TG2: Lynch syndrome and polyposis.

  • TG3: Hereditary breast and ovarian cancer.

  • TG4: Other rare syndromes - predominantly malignant.

 

The objectives of ERN GENTURIS are to:

  • Improve the identification of people with genetic tumour risk syndrome.

  • Reduce variation in practice and clinical outcomes.

  • Develop evidence-based clinical guidelines.

  • Develop and use patient registries, biobanks and research studies.

  • Define healthcare pathways designed to facilitate better access to international clinical expertise for patients and their families living across the EU.

  • Develop and use pan-European patient registries, biobanks and research studies.